{"id":"https://openalex.org/W2010448327","doi":"https://doi.org/10.1038/clpt.2013.81","title":"In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development","display_name":"In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development","publication_year":2013,"publication_date":"2013-04-10","ids":{"openalex":"https://openalex.org/W2010448327","doi":"https://doi.org/10.1038/clpt.2013.81","mag":"2010448327","pmid":"https://pubmed.ncbi.nlm.nih.gov/23588315"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2013.81","doi":"https://doi.org/10.1038/clpt.2013.81","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2013.81","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2013.81","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2013.81","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056589677","display_name":"Kim L. R. Brouwer","orcid":"https://orcid.org/0000-0003-1945-4929","observed_orcids":["https://orcid.org/0000-0003-1945-4929"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"K L R Brouwer","raw_affiliation_strings":["Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. kbrouwer@unc.edu","Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. kbrouwer@unc.edu","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Division of Pharmacotherapy and Experimental Therapeutics UNC Eshelman School of Pharmacy The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002662351","display_name":"Dietrich O. R. KEPPLER","orcid":"https://orcid.org/0000-0003-2964-2333","observed_orcids":["https://orcid.org/0000-0003-2964-2333"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D Keppler","raw_affiliation_strings":["German Cancer Research Center, Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Cancer Research Center, Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022971135","display_name":"Keith A. Hoffmaster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K A Hoffmaster","raw_affiliation_strings":["Novartis Institutes for BioMedical Research, Metabolism and Pharmacokinetics, Cambridge, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Institutes for BioMedical Research, Metabolism and Pharmacokinetics, Cambridge, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091873352","display_name":"Daniel A.J. Bow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D A J Bow","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101620925","display_name":"Yaofeng Cheng","orcid":"https://orcid.org/0000-0002-3875-3070","observed_orcids":["https://orcid.org/0000-0002-3875-3070"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Cheng","raw_affiliation_strings":["Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058112913","display_name":"Yurong Lai","orcid":"https://orcid.org/0000-0001-9505-333X","observed_orcids":["https://orcid.org/0000-0001-9505-333X"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y Lai","raw_affiliation_strings":["Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Princeton, New Jersey, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072935114","display_name":"Johan E. Palm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J E Palm","raw_affiliation_strings":["CVGI iMed DMPK, Innovative Medicines, AstraZeneca R&D Mo\u0308lndal, Mo\u0308lndal, Sweden","CVGI iMed DMPK, Innovative Medicines, AstraZeneca R&D M\u00f6lndal M\u00f6lndal Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CVGI iMed DMPK, Innovative Medicines, AstraZeneca R&D Mo\u0308lndal, Mo\u0308lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"CVGI iMed DMPK, Innovative Medicines, AstraZeneca R&D M\u00f6lndal M\u00f6lndal Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042283235","display_name":"Bruno Stieger","orcid":"https://orcid.org/0000-0002-7190-5785","observed_orcids":["https://orcid.org/0000-0002-7190-5785"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"B Stieger","raw_affiliation_strings":["Department of Clinical Pharmacology and Toxicology, University Hospital, Zurich, Switzerland","Department of Clinical Pharmacology and Toxicology, University Hospital, Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Toxicology, University Hospital, Zurich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Toxicology, University Hospital, Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064222916","display_name":"Raymond Evers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R Evers","raw_affiliation_strings":["Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Rahway, New Jersey, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co., Rahway, New Jersey, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5056589677","https://openalex.org/A5064222916"],"corresponding_institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1285764155"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":3.3308,"has_fulltext":true,"cited_by_count":273,"citation_normalized_percentile":{"value":0.95217391,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"94","issue":"1","first_page":"95","last_page":"112"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.8889999985694885},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6610000133514404}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6778223514556885},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5836676359176636},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5108453631401062},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.488071084022522},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.467756986618042},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44630712270736694},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4249490797519684},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33268821239471436},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3127201795578003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3077166676521301},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22638893127441406},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2132473886013031},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09277462959289551},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08500078320503235}],"mesh":[{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1038/clpt.2013.81","doi":"https://doi.org/10.1038/clpt.2013.81","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2013.81","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2013.81","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:23588315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23588315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:93549","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/93549/1/clpt201381a.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/93549/1/clpt201381a.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brouwer, K L R; Keppler, D; Hoffmaster, K A; Bow, D A J; Cheng, Y; Lai, Y; Palm, J E; Stieger, B; Evers, R (2013). In vitro methods to support transporter evaluation in drug discovery and development. Clinical Pharmacology and Therapeutics, 94(1):95-112.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:cdr.lib.unc.edu:xd07h243h","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.17615/13r3-3281","pdf_url":null,"source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology & Therapeutics (Nature), 94(1)","raw_type":"Article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/103061","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/103061","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brouwer, K. L. R., Keppler, D., Hoffmaster, K. A., Bow, D. A. J., Cheng, Y., Lai, Y., Palm, J. E., Stieger, B., & Evers, R. (2013). In vitro methods to support transporter evaluation in drug discovery and development. Clinical Pharmacology and Therapeutics, 94, 95\u2013112. https://doi.org/10.1038/clpt.2013.81","raw_type":"Journal Article"},{"id":"doi:10.17615/13r3-3281","doi":"https://doi.org/10.17615/13r3-3281","is_oa":true,"landing_page_url":"https://doi.org/10.17615/13r3-3281","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.5167/uzh-93549","doi":"https://doi.org/10.5167/uzh-93549","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-93549","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1038/clpt.2013.81","doi":"https://doi.org/10.1038/clpt.2013.81","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2013.81","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2013.81","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3230350167","display_name":"Altered Hepatic Disposition of Anionic Drugs-Mechanisms","funder_award_id":"R01GM041935","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2010448327.pdf","grobid_xml":"https://content.openalex.org/works/W2010448327.grobid-xml"},"referenced_works_count":72,"referenced_works":["https://openalex.org/W37542439","https://openalex.org/W55289074","https://openalex.org/W97964894","https://openalex.org/W109648843","https://openalex.org/W1275052218","https://openalex.org/W1508816133","https://openalex.org/W1520219484","https://openalex.org/W1524617127","https://openalex.org/W1668171077","https://openalex.org/W1904678284","https://openalex.org/W1947303611","https://openalex.org/W1969022737","https://openalex.org/W1975742715","https://openalex.org/W1977837914","https://openalex.org/W1985443358","https://openalex.org/W1985785813","https://openalex.org/W1990359955","https://openalex.org/W2001838995","https://openalex.org/W2013322396","https://openalex.org/W2014051119","https://openalex.org/W2015574368","https://openalex.org/W2021233291","https://openalex.org/W2023648745","https://openalex.org/W2023782842","https://openalex.org/W2027665912","https://openalex.org/W2030404781","https://openalex.org/W2030434950","https://openalex.org/W2034245991","https://openalex.org/W2036741913","https://openalex.org/W2039693707","https://openalex.org/W2047527636","https://openalex.org/W2048288973","https://openalex.org/W2050957984","https://openalex.org/W2053613516","https://openalex.org/W2054131280","https://openalex.org/W2057584545","https://openalex.org/W2064413682","https://openalex.org/W2070972281","https://openalex.org/W2071101614","https://openalex.org/W2072451809","https://openalex.org/W2072784247","https://openalex.org/W2076027662","https://openalex.org/W2079197876","https://openalex.org/W2079222907","https://openalex.org/W2085134666","https://openalex.org/W2091547137","https://openalex.org/W2098195698","https://openalex.org/W2099086608","https://openalex.org/W2099486478","https://openalex.org/W2102551031","https://openalex.org/W2104340319","https://openalex.org/W2105114886","https://openalex.org/W2108982217","https://openalex.org/W2110057699","https://openalex.org/W2110942596","https://openalex.org/W2116232204","https://openalex.org/W2117748821","https://openalex.org/W2120152745","https://openalex.org/W2121102751","https://openalex.org/W2123794295","https://openalex.org/W2129233012","https://openalex.org/W2132107140","https://openalex.org/W2133464603","https://openalex.org/W2134837921","https://openalex.org/W2145481170","https://openalex.org/W2145804243","https://openalex.org/W2147566151","https://openalex.org/W2147787974","https://openalex.org/W2152964734","https://openalex.org/W2158351297","https://openalex.org/W2165423709","https://openalex.org/W2167088871"],"related_works":["https://openalex.org/W7128988893","https://openalex.org/W3043692578","https://openalex.org/W2901299151","https://openalex.org/W1975607528","https://openalex.org/W8766861","https://openalex.org/W3042647732","https://openalex.org/W2607922282","https://openalex.org/W4283165504","https://openalex.org/W4303426750","https://openalex.org/W146817154"],"abstract_inverted_index":{"This":[0],"white":[1],"paper":[2],"addresses":[3],"current":[4],"approaches":[5,67],"and":[6,39,66],"knowledge":[7],"gaps":[8],"concerning":[9],"methods":[10,44],"to":[11,30,48,68],"assess":[12,49],"the":[13,50,70],"role":[14],"of":[15,52,72],"transport":[16],"proteins":[17],"in":[18,21,27,34,59,74],"drug/metabolite":[19],"disposition":[20,76],"humans.":[22],"The":[23],"discussion":[24],"focuses":[25],"on":[26],"vitro":[28],"tools":[29],"address":[31],"key":[32],"questions":[33],"drug":[35,75],"development,":[36],"including":[37],"vesicle-":[38],"cell-based":[40],"systems.":[41],"How":[42],"these":[43],"can":[45],"be":[46],"used":[47],"liability":[51],"compounds":[53],"for":[54],"transporter-based":[55],"drug-drug":[56],"interactions":[57],"(DDIs)":[58],"vivo":[60],"is":[61],"also":[62],"explored.":[63],"Existing":[64],"challenges":[65],"examine":[69],"involvement":[71],"transporters":[73],"are":[77],"discussed.":[78]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":27},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":25},{"year":2017,"cited_by_count":25},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":28},{"year":2013,"cited_by_count":10}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}